Genetic Technologies Limited operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genetic Technologies Limited with three other
pharmaceutical manufacturers in Australasia:
Prescient Therapeutics Ltd
(2021
sales of 66,285.00 Australian Dollars [US$48,312.49 ]
of which 100%
was Clinical stage oncology),
Rhythm Biosciences Ltd
(13,973.00 Australian Dollars [US$10,184.36 ]
), and
Alterity Therapeutics Ltd
(20,676.00 Australian Dollars [US$15,069.91 ]
of which 100%
was Reaserch and development in the field of).
Sales Analysis.
Sales increased substantially in 2021:
Genetic Technologies Limited reported sales of A$120,554.00 (US$87.87 thousand)
for the
fiscal
year ending
June of 2021.
This
represents
an
increase of 1,122.2%
versus 2020, when the company's sales were A$9,864.00 .